GPT and metabolic dysfunction-associated steatotic liver disease: NT AUROCs for the diagnosis of NASH or borderline NASH in NAFLD were unchanged in patients with ALT values lower than 50 IU/L (Table 6 and Table 7); therefore NT could be used to diagnose NASH even in patients that are not eligible for liver biopsy.